Home
About
Overview
Sharing Data
ORCID
Help
History (9)
The Relationship between Anthropometric Indices and Breast Cancer in Central Iran.
Selenium Metabolism and Renal Disease
Mifepristone implementation in primary care: Clinician and staff insights from a pilot learning collaborative.
Co-Investigator
Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias.
Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias. Front Immunol. 2025; 16:1558275.
View in:
PubMed
subject areas
Humans
Immunoglobulin Light-chain Amyloidosis
Immunotherapy, Adoptive
Leukemia, Plasma Cell
Paraproteinemias
Treatment Outcome
authors with profiles
Benjamin Derman